London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950

Our Clients

Order Informer

Home > News >

BASF Venture Capital invests in German biotechnology company

August 31/2011

(BASF) -- baseclick GmbH, a spin-off from BASF SE and Ludwig-Maximilians-Universitat Munich, raised an additional EUR 1.2 million from private investors and BASF Venture Capital, the largest single investor, in the second round of financing. The start-up company baseclick GmbH, founded in the year 2008, is located in Tutzing, Germany, and holds technology patents in labeling processes of deoxyribonucleic acid (DNA).

УWe will use the capital raised to expand our existing activities in DNA-technologies,Ф says Dr. Thomas Frischmuth, General Manager of baseclick GmbH. In addition, the company will build up a business for diagnostic technologies.
The baseclick technology is based on click chemistry research by Professor Barry Sharpless (Nobel Prize in Chemistry, 2001) of The Scripps Research Institute, La Jolla, California. Professor Thomas Carell of Ludwig-Maximilians-Universitat Munich, Germany, has advanced the technology so that nucleic acids can be modified.

Category:General News
| More

Leave a comment

MRC help


 All News   News subscribe